Overview

Effect of Testosterone Replacement on Insulin Resistance

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study aims to determine whether testosterone replacement improves insulin sensitivity in non-obese men with low testosterone and the metabolic syndrome. The metabolic syndrome includes three of the following five conditions, 1) an elevated blood pressure (greater than 130/85), 2) a triglyceride level greater than 150 mg/dl, 3) an HDL-cholesterol less than 40 mg/dl, 4) glucose levels greater than 100 mg/dl, and 5) a waist measurement greater than 40 inches.
Phase:
Phase 4
Details
Lead Sponsor:
McGuire Research Institute
Collaborator:
Solvay Pharmaceuticals
Treatments:
Insulin
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate